Skip to main content
MedPathMedPath Home
Clinical Trials/NL-OMON30319
NL-OMON30319
Completed
Not Applicable

A randomized clinical trial of excision versus photodynamic therapy in the treatment of Bowen's disease - Morbus Bowen: excision versus photodynamic therapie

Catharina-ziekenhuis0 sites224 target enrollmentTBD
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsIntraepithelial squamous cell carcinomaskincancer1004090010040795

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Intraepithelial squamous cell carcinoma
Sponsor
Catharina-ziekenhuis
Enrollment
224
Status
Completed
Last Updated
last year
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
last year
Study Type
Interventional

Investigators

Eligibility Criteria

Inclusion Criteria

  • •Histopathologic proven Bowen's disease scalp, face, torso, arms and legs
  • •Age \> 18 years
  • •Informed consent

Exclusion Criteria

  • •Recurrent Bowen's disease
  • •Anogenital or subungual Bowen's disease
  • •Other skin malagnancies in the same area

Outcomes

Primary Outcomes

Not specified

Similar Trials

Completed
Not Applicable
A prospective randomised trial of resection versus biopsy in patients with malignant gliomaCancerBrain
ISRCTN48935548Medical Research Council (MRC) (UK)
Completed
Not Applicable
Randomised trial of width of surgical excision of thick cutaneous malignant melanomaMalignant melanomaCancer
ISRCTN13411879K Co-ordinating Committee for Cancer Research (UKCCCR)
Completed
Phase 3
A randomized controlled trial comparing resection of primary tumor plus chemotherapy with chemotherapy alone in incurable Stage IV colorectal cancer(JCOG1007, iPACS)nresectable Stage IV colorectal cancer and a synchronous asymptomatic primary tumor
JPRN-UMIN000008147Japan Clinical Oncology Group (JCOG)770
Active, not recruiting
Phase 3
A randomised controlled trial of excisional surgery versus imiquimod 5% cream for nodular and superficial basal cell carcinoma.low risk superficial basal cell carcinomalow risk nodular basal cell carcinomaSkin - Dermatological conditionsCancer - Non melanoma skin cancer
ACTRN12611001083987niversity of Nottingham500
Completed
Phase 2
Reconstruction of major extensive facial burn injuriesFacial Burn.Burns and corrosionsT20, T21,
IRCT201307319044N2Vice chancellor for research, Iran University of Medical Sciences60